Treatment Patterns among FGFR-Positive Metastatic Urothelial Carcinoma Patients: A NorstellaLinQ Claims and EHR Analysis
Characterizing FGFR Biomarker Testing in Metastatic Urothelial Carcinoma through NorstellaLinQ Linked Claims and Electronic Health Records, Including Clinical Notes with Human-in-the-Loop LLM Extraction
Unstructured Clinical Notes as a Source of Non-Small Cell Lung Cancer (NSCLC) Biomarker Information beyond Structured Data: Evidence from NorstellaLinQ Real-World Data
Diagnosis-Based Healthcare Organization Attribution Frequently Misclassifies Treating Organizations in Breast Cancer: A Real-World Analysis Using NorstellaLinQ EHR and Claims
Finding Patients Before They’re Lost: Digital Twins and Prediction in Relapsed/Refractory Multiple Myeloma (RRMM)
Identifying Oligometastatic Breast Cancer in Real-World Data Using Clinical Notes and Treatment Signals Leveraging NorstellaLinQ Electronic Health Records
Real-World Analysis of Treatment Delays in Metastatic Non-Small Cell Lung Cancer: Demographic, Clinical, and Payer Drivers
Variations in Lines of Treatment and Clinical Outcomes in US Health System Patients with Locally Advanced, Inoperable or Metastatic Triple Negative Breast Cancer (la/m TNBC)
Cost Impact of Disease Progression to Metastases in Patients with Gastric or Gastroesophageal Junction Cancer in the USA (Not Yet Submitted or Accepted)
Treatment Patterns, Health Care Resource Utilization and Clinical Outcomes among patients with Extensive-Stage Small Cell Lung Cancer